← Back to patent-cliff list
Fosfluconazole
Tier C — Watch / tradeFosfluconazole
Pfizer Inc.
Originator
2003
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：CYP51A1
Brand：Prodif
Indications (approved)：Candidiasis, 新型隐球菌感染, Fungal infection
Regional status
US
-
EU
-
China
IND filed
2015-10-15
Japan
Approved
2003-10-16
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Fosfluconazole?
Approved indications include: Candidiasis, 新型隐球菌感染, Fungal infection.
When does the Fosfluconazole patent expire?
No public expiry year is available for Fosfluconazole yet; this page updates once verified.
How do I get a quote for Fosfluconazole intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27